15964290

Source:http://linkedlifedata.com/resource/pubmed/id/15964290

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0032961, umls-concept:C0085174, umls-concept:C0127400, umls-concept:C0205531, umls-concept:C0226896, umls-concept:C0333348, umls-concept:C0442027, umls-concept:C0600454, umls-concept:C1280500, umls-concept:C1363844, umls-concept:C1521801, umls-concept:C1527415
pubmed:issue	1
pubmed:dateCreated	2005-6-20
pubmed:abstractText	The objective of the present study was to investigate the effect of vaginally and orally administered misoprostol on the local cervical inflammatory response.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0234361
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Abortifacient Agents, Nonsteroidal, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD45, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Differentiation..., http://linkedlifedata.com/resource/pubmed/chemical/CD68 antigen, human, http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 8, http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 9, http://linkedlifedata.com/resource/pubmed/chemical/Misoprostol, http://linkedlifedata.com/resource/pubmed/chemical/Tissue Inhibitor of..., http://linkedlifedata.com/resource/pubmed/chemical/Tissue Inhibitor of...
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0010-7824
pubmed:author	pubmed-author:AronssonAnnetteA, pubmed-author:Gemzell-DanielssonKristinaK, pubmed-author:StåbiBeritB, pubmed-author:Stavreus-EversAnneliA, pubmed-author:UlfgrenAnn-KristinAK
pubmed:issnType	Print
pubmed:volume	72
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	33-9
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:15964290-Abortifacient Agents, Nonsteroidal, pubmed-meshheading:15964290-Abortion, Induced, pubmed-meshheading:15964290-Administration, Intravaginal, pubmed-meshheading:15964290-Administration, Oral, pubmed-meshheading:15964290-Adult, pubmed-meshheading:15964290-Antigens, CD, pubmed-meshheading:15964290-Antigens, CD45, pubmed-meshheading:15964290-Antigens, Differentiation, Myelomonocytic, pubmed-meshheading:15964290-Cervical Ripening, pubmed-meshheading:15964290-Female, pubmed-meshheading:15964290-Gestational Age, pubmed-meshheading:15964290-Humans, pubmed-meshheading:15964290-Immunohistochemistry, pubmed-meshheading:15964290-Inflammation, pubmed-meshheading:15964290-Matrix Metalloproteinase 8, pubmed-meshheading:15964290-Matrix Metalloproteinase 9, pubmed-meshheading:15964290-Misoprostol, pubmed-meshheading:15964290-Pregnancy, pubmed-meshheading:15964290-Tissue Inhibitor of Metalloproteinase-1, pubmed-meshheading:15964290-Tissue Inhibitor of Metalloproteinase-2, pubmed-meshheading:15964290-Vacuum Curettage
pubmed:year	2005
pubmed:articleTitle	The effect of orally and vaginally administered misoprostol on inflammatory mediators and cervical ripening during early pregnancy.
pubmed:affiliation	Department of Woman and Child Health, Division for Obstetrics and Gynecology, Karolinska Institute, S-171 76 Stockholm, Sweden.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't